Artisan Bio to highlight CRISPR platform at Cell & Gene Meeting

By The Science Advisory Board staff writers

October 11, 2021 -- Artisan Bio plans to highlight its CRISPR-engineered cell therapy platform at the Cell & Gene Meeting on the Mesa in Carlsbad, CA.

The company's STAR platform consists of a family of endonuclease-based editing systems to produce cell therapy design candidates. Artisan Bio has validated the platform with T cells, induced pluripotent stem cells and cancer cells, as well as industrial cell lines like CHO and HEK293, it said.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.